Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&# | CDC RFA GH16 171602CONT17

Opportunity Information: Apply for CDC RFA GH16 171602CONT17

This funding opportunity is a continuation cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), under the President's Emergency Plan for AIDS Relief (PEPFAR). Its focus is Kenya, specifically the Western and Rift Valley regions, and the core intent is to expand and sustain access to high quality, comprehensive health services and structural interventions for key populations and priority populations that are most affected by HIV and related health challenges. The program emphasizes not only delivering clinical and prevention services, but also addressing the social, legal, and systemic barriers that keep these groups from consistently accessing care.

A key feature of this notice is that it is not an open competition. It is explicitly labeled as continuation funding, meaning the funds are intended only for organizations that previously received awards under the earlier CDC funding opportunity CDC-RFA-GH16-1716, which carried the same program title and scope. In practical terms, eligibility is limited to those existing grantees, and the continuation mechanism is designed to maintain momentum and avoid disruptions in services already being delivered in these regions. The listing shows "Eligible Applicants: Others," but the description makes clear the continuation restriction to prior awardees.

The award instrument is a cooperative agreement, which generally means CDC expects to have substantial involvement in the funded activities, such as collaborating on technical approaches, monitoring performance, supporting data use for improvement, and ensuring alignment with PEPFAR strategies and reporting requirements. The activity category is health, and the CFDA number attached to the opportunity is 93.067, which corresponds to CDC global HIV/AIDS activities. The opportunity anticipated up to 10 awards, reflecting multiple implementing partners or geographically distributed service delivery efforts, although the specific award ceiling is listed as 0 in the provided data, which typically indicates that the ceiling is either not set in the abstracted record, is determined through continuation budgets, or is defined in the underlying award documents rather than in a standard competitive ceiling format.

Programmatically, the title and description point to a comprehensive package for key and priority populations, which in PEPFAR programming commonly includes a mix of HIV prevention, HIV testing services, linkage to care, antiretroviral treatment support, retention and adherence services, sexually transmitted infection screening and treatment, condom and lubricant programming, and targeted outreach. The mention of "structural interventions" indicates an emphasis on the upstream factors that affect health outcomes, such as stigma and discrimination, violence and safety concerns, legal and policy barriers, economic vulnerability, and gaps in community-level support systems. These structural components are often implemented through community mobilization, peer navigation models, violence prevention and response systems, rights literacy, provider sensitivity training, and building referral networks that reduce drop-off between testing, prevention services, and sustained treatment.

From an administrative standpoint, the opportunity number is CDC RFA GH16 171602CONT17, the original closing date was March 31, 2017, and the record creation date is January 30, 2017. Those dates fit the pattern of a time-limited continuation announcement connected to an existing project period, rather than a new solicitation seeking fresh applicants. Overall, the notice signals CDC's intent to continue investing PEPFAR resources in established partners to maintain and strengthen service delivery for populations at elevated HIV risk in Western and Rift Valley Kenya, with an emphasis on sustainability, quality, and comprehensive programming that combines clinical services with barrier-reducing structural support.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&#" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2017-01-30.
• Applicants must submit their applications by 2017-03-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH16 171602CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: